Ravelcare Limited has announced the launch of its new product line, Ravel PRO, and an upcoming AI-powered diagnostic skincare range. This strategic move expands the company’s market presence into quick-commerce and mass markets, aiming for significant revenue growth. The Ravel PRO range focuses on targeted solutions for hair fall, dandruff, and damage repair, with the AI skincare line set to launch in H2 FY27.
Ravelcare Expands Product Portfolio
Ravelcare Limited has officially launched its new product line, Ravel PRO, and revealed plans for an upcoming AI-powered diagnostic skincare range. This dual initiative marks a significant expansion for the company, moving beyond its traditional personalized haircare business into broader e-commerce and quick-commerce platforms.
Ravel PRO: Expanding Market Reach
The Ravel PRO range, featuring shampoos, conditioners, scalp masks, treatments, and scalp oil shots, addresses five key concerns: hair fall, dandruff, damage repair, hair growth, and premature greying. Launched on top e-commerce and quick-commerce platforms, Ravel PRO has already contributed approximately 20% incremental revenue in its first full month. The products are available on major platforms including ravelcare.com, Amazon, Flipkart, Nykaa, Myntra, and Blinkit.
AI-Driven Skincare on the Horizon
Looking ahead, Ravelcare is set to introduce an AI-led diagnostic skincare range in the second half of FY27. This innovative line will utilize a photo-based skin analysis to build personalized routines, shifting the company’s approach from questionnaire-based personalization to diagnosis-led solutions. This move is expected to strengthen Ravelcare’s position as a technology-led brand in the competitive skincare market.
Synergy and Future Growth
The company anticipates significant synergies across its three verticals: personalized haircare, Ravel PRO, and the upcoming AI skincare. This integrated approach aims to leverage a single consultation engine, supply chain, and marketing team, creating cross-sell opportunities for all acquired customers. Ravelcare expects this strategic expansion, coupled with its growing presence on marketplaces, to drive healthy growth in FY27.
Source: BSE
